Search

Your search keyword '"Rose Do"' showing total 35 results

Search Constraints

Start Over You searched for: Author "Rose Do" Remove constraint Author: "Rose Do" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
35 results on '"Rose Do"'

Search Results

1. Cataract Surgery in the Medicare Merit-Based Incentive Payment System

4. Safety of the BNT162b2 COVID-19 Vaccine in Children Aged 5 to 17 Years

5. Evaluation of Potential Adverse Events Following COVID-19 mRNA Vaccination Among Adults Aged 65 Years and Older: A Self-Controlled Study in the U.S

7. Development of a Knee Arthroplasty Episode-Based Cost Measure for Evaluating Cost in the Merit-Based Incentive Payment System

8. Results of safety monitoring of BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine in U.S. children aged 5-17 years

9. Development of Episode-Based Cost Measures for the US Medicare Merit-based Incentive Payment System

10. Surveillance of COVID-19 vaccine safety among elderly persons aged 65 years and older

11. Patient Preference for Subcutaneous Versus Intravenous Administration with Every-6-Week Natalizumab (Tysabri®) Dosing: NOVA Phase IIIb Extension Study (Part 2)

12. Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases

13. Adjustment For Social Risk Factors Does Not Meaningfully Affect Performance On Medicare’s MIPS Clinician Cost Measures

14. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

17. Seasonal influenza vaccination is associated with reduced risk of death among Medicare beneficiaries

18. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

20. Development of the Elective Outpatient Percutaneous Coronary Intervention Episode-Based Cost Measure

21. Development of a Cost Measure for Screening/Surveillance Colonoscopy for the Merit-Based Incentive Payment System

22. Surveillance of COVID-19 Vaccine Safety Among Elderly Persons Aged 65 Years and Older

23. Adjustment For Social Risk Factors Does Not Meaningfully Affect Performance On Medicare's MIPS Clinician Cost Measures

24. Abstract 176: Association Between Hospital-Level Cost of Cardiovascular Care and Socioeconomic Characteristics

25. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

26. Characterization and comparison of human and mouse milk cells.

27. Understanding the impact of 'cost' under MACRA: a neurointerventional imperative!

28. JANELAS DE EXPERIÊNCIAS: ENTRE OBRAS E LAGARTOS

29. Hemodynamic effects of IV sodium nitrite in hospitalized comatose survivors of out of hospital cardiac arrest

30. The Impact of Tobacco Smoking on One Year Patient Outcomes at a Family Medicine Residency Clinic

31. Long‐term daily oral administration of intestinal permeation enhancers is safe and effective in mice

32. Generalized Cost-Effectiveness of Residential Wind Mitigation Strategies for Wood-Frame, Single Family House in the USA

33. The differential impact of pediatric COVID-19 between high-income countries and low- and middle-income countries: A systematic review of fatality and ICU admission in children worldwide.

34. Design for a Mail Survey to Determine Prevalence of SARS-CoV-2 (COVID-19) Antibodies in the United States

35. Adjustment For Social Risk Factors Does Not Meaningfully Affect Performance On Medicare's MIPS Clinician Cost Measures.

Catalog

Books, media, physical & digital resources